Clinical Trial Update: Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus [Phase 2]

View source ↗

Summary

Phase 2 trial update on treating newly diagnosed moderate to severe chronic graft-versus-host disease with prednisone and everolimus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Everolimus (everolimus)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Chronic Graft-versus-host Disease | Phase 2 | Status: COMPLETED